NCT05319587 / 2020-005493-10: Study of Liposomal Annamycin in Combination with Cytarabine for the Treatment of Subjects with Acute Myeloid Leukemia (AML) |
|
|
| Active, not recruiting | 1/2 | 63 | Europe | Liposomal Annamycin, Cytarabine | Moleculin Biotech, Inc., Moleculin Biotech, Inc. | Leukemia, Myeloid, Acute | 08/23 | 04/25 | | |